Literature DB >> 23951501

Serotonin: good or bad for bone.

Marie-Christine de Vernejoul1, Corinne Collet, Yasmine Chabbi-Achengli.   

Abstract

Besides its action as a neurotransmitter, serotonin has multiple physiological functions in several peripheral organs. Recently, Yadav et al. suggested that peripheral serotonin produced in the gut was a major negative regulator of osteoblast proliferation. These data were challenged by Cui et al. that showed no change in bone density in mature mice with a global invalidation of tryptophan hydroxylase 1, the enzyme responsible of serotonin synthesis in the periphery. In this context, we showed that osteoclasts are able to synthetize serotonin that acts locally to induce osteoclast precursors differentiation. Our data and previous results from others suggest that rather than acting as a hormone, serotonin produced in the bone could act locally on osteoclast and osteoblast realizing in the bone a complete micro-serotoninergic system.

Entities:  

Year:  2012        PMID: 23951501      PMCID: PMC3727814          DOI: 10.1038/bonekey.2012.120

Source DB:  PubMed          Journal:  Bonekey Rep        ISSN: 2047-6396


  43 in total

1.  Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth.

Authors:  Stuart J Warden; Alexander G Robling; Megan S Sanders; Michael M Bliziotes; Charles H Turner
Journal:  Endocrinology       Date:  2004-11-11       Impact factor: 4.736

2.  Long-term serotonin administration leads to higher bone mineral density, affects bone architecture, and leads to higher femoral bone stiffness in rats.

Authors:  Björn I Gustafsson; Irene Westbroek; Jan H Waarsing; Helge Waldum; Erik Solligård; Anders Brunsvik; Sigbjørn Dimmen; Johannes P T M van Leeuwen; Harrie Weinans; Unni Syversen
Journal:  J Cell Biochem       Date:  2006-04-15       Impact factor: 4.429

3.  Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin.

Authors:  Amy K L Banes; Seán M Shaw; Amany Tawfik; Bela P Patel; Safia Ogbi; David Fulton; Mario B Marrero
Journal:  Am J Physiol Cell Physiol       Date:  2004-12-15       Impact factor: 4.249

4.  Serotonin 2B receptor is required for heart development.

Authors:  C G Nebigil; D S Choi; A Dierich; P Hickel; M Le Meur; N Messaddeq; J M Launay; L Maroteaux
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

5.  Neurotransmitter action in osteoblasts: expression of a functional system for serotonin receptor activation and reuptake.

Authors:  M M Bliziotes; A J Eshleman; X W Zhang; K M Wiren
Journal:  Bone       Date:  2001-11       Impact factor: 4.398

6.  Pharmacological inhibition of gut-derived serotonin synthesis is a potential bone anabolic treatment for osteoporosis.

Authors:  Vijay K Yadav; Santhanam Balaji; Padmanaban S Suresh; X Sherry Liu; Xin Lu; Zhishan Li; X Edward Guo; J John Mann; Anil K Balapure; Michael D Gershon; Rudraiah Medhamurthy; Marc Vidal; Gerard Karsenty; Patricia Ducy
Journal:  Nat Med       Date:  2010-02-07       Impact factor: 53.440

7.  Serotonin has a key role in pathogenesis of experimental colitis.

Authors:  Jean-Eric Ghia; Nan Li; Huaqing Wang; Matthew Collins; Yikang Deng; Rami T El-Sharkawy; Francine Côté; Jacques Mallet; Waliul I Khan
Journal:  Gastroenterology       Date:  2009-08-23       Impact factor: 22.682

8.  Serotonylation of small GTPases is a signal transduction pathway that triggers platelet alpha-granule release.

Authors:  Diego J Walther; Jens-Uwe Peter; Sandra Winter; Markus Höltje; Nils Paulmann; Maik Grohmann; Jakob Vowinckel; Victor Alamo-Bethencourt; Claudia S Wilhelm; Gudrun Ahnert-Hilger; Michael Bader
Journal:  Cell       Date:  2003-12-26       Impact factor: 41.582

9.  Maternal serotonin influences cardiac function in adult offspring.

Authors:  Cécile Fligny; Yves Fromes; Philippe Bonnin; Michèle Darmon; Elisa Bayard; Jean-Marie Launay; Francine Côté; Jacques Mallet; Guilan Vodjdani
Journal:  FASEB J       Date:  2008-02-11       Impact factor: 5.191

10.  Lrp5 functions in bone to regulate bone mass.

Authors:  Yajun Cui; Paul J Niziolek; Bryan T MacDonald; Cassandra R Zylstra; Natalia Alenina; Daniel R Robinson; Zhendong Zhong; Susann Matthes; Christina M Jacobsen; Ronald A Conlon; Robert Brommage; Qingyun Liu; Faika Mseeh; David R Powell; Qi M Yang; Brian Zambrowicz; Han Gerrits; Jan A Gossen; Xi He; Michael Bader; Bart O Williams; Matthew L Warman; Alexander G Robling
Journal:  Nat Med       Date:  2011-05-22       Impact factor: 53.440

View more
  12 in total

1.  Gut-derived serotonin contributes to bone deficits in colitis.

Authors:  B Lavoie; J A Roberts; M M Haag; S N Spohn; K G Margolis; K A Sharkey; J B Lian; G M Mawe
Journal:  Pharmacol Res       Date:  2018-07-17       Impact factor: 7.658

2.  Peripartum dietary supplementation of a small-molecule inhibitor of tryptophan hydroxylase 1 compromises infant, but not maternal, bone.

Authors:  Samantha R Weaver; Hannah P Fricke; Cynthia Xie; Robert J Aiello; Julia F Charles; Laura L Hernandez
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-10-23       Impact factor: 4.310

3.  Adult Tph2 knockout mice without brain serotonin have moderately elevated spine trabecular bone but moderately low cortical bone thickness.

Authors:  Robert Brommage; Jeff Liu; Deon Doree; Wangsheng Yu; David R Powell; Qi Melissa Yang
Journal:  Bonekey Rep       Date:  2015-07-15

Review 4.  Effects of Depression and Serotonergic Antidepressants on Bone: Mechanisms and Implications for the Treatment of Depression.

Authors:  Brisa S Fernandes; Jason M Hodge; Julie A Pasco; Michael Berk; Lana J Williams
Journal:  Drugs Aging       Date:  2016-01       Impact factor: 3.923

Review 5.  Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy.

Authors:  Bipradas Roy; Mary E Curtis; Letimicia S Fears; Samuel N Nahashon; Hugh M Fentress
Journal:  Front Physiol       Date:  2016-09-29       Impact factor: 4.566

6.  Clomipramine causes osteoporosis by promoting osteoclastogenesis via E3 ligase Itch, which is prevented by Zoledronic acid.

Authors:  Xing Li; Wen Sun; Jinbo Li; Mengmeng Wang; Hengwei Zhang; Lingpeng Pei; Brendan F Boyce; Zhiyu Wang; Lianping Xing
Journal:  Sci Rep       Date:  2017-02-01       Impact factor: 4.379

Review 7.  Relationships between Bone Turnover and Energy Metabolism.

Authors:  Tânia A P Fernandes; Luísa M L Gonçalves; José A A Brito
Journal:  J Diabetes Res       Date:  2017-06-11       Impact factor: 4.011

8.  Metabolomics Based Profiling of Dexamethasone Side Effects in Rats.

Authors:  Abeer K Malkawi; Karem H Alzoubi; Minnie Jacob; Goran Matic; Asmaa Ali; Achraf Al Faraj; Falah Almuhanna; Majed Dasouki; Anas M Abdel Rahman
Journal:  Front Pharmacol       Date:  2018-02-16       Impact factor: 5.810

9.  Systemic effects of fluoxetine on the amount of tooth movement, root resorption, and alveolar bone remodeling during orthodontic force application in rat.

Authors:  Mehdi Rafiei; Soosan Sadeghian; Nakisa Torabinia; Valiollah Hajhashemi
Journal:  Dent Res J (Isfahan)       Date:  2015 Sep-Oct

10.  Dysregulation of 5-hydroxytryptamine 6 receptor accelerates maturation of bone-resorbing osteoclasts and induces bone loss.

Authors:  Kyung-Ran Park; Eun-Cheol Kim; Jin Tae Hong; Hyung-Mun Yun
Journal:  Theranostics       Date:  2018-04-30       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.